Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01901783 · ClinicalTrials.gov registry record · NA
Ridge Augmentation Without Primary Closure
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01901783: Completed NA study, sponsored by University of Louisville.
NCT01901783 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01901783, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study is designed to compare the clinical and histologic results of ridge augmentation with and without primary closure over the barrier membrane. The hypothesis is that there will be no difference in crestal ridge width between the two groups.
Primary Outcome
The ridge width at the crest will be compared between the two treatment groups.
Interventions
- PROCEDURE With primary closure
- PROCEDURE Without primary closure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT01901783 record still lists
NCT01901783 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which With primary closure is the first listed.
NCT01901783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01901783 about?
NCT01901783 is a clinical study titled "Ridge Augmentation Without Primary Closure". This study is designed to compare the clinical and histologic results of ridge augmentation with and without primary closure over the barrier membrane. The hypothesis is that there will be no difference in crestal ridge width between the two groups.
What is the current status of trial NCT01901783?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2013-09. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01901783?
The interventions under investigation include: With primary closure (PROCEDURE), Without primary closure (PROCEDURE).
Who is sponsoring clinical trial NCT01901783?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01901783's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia